Berg Media

BERG Announces Presentation Of Multiple Interrogative Biology Platform® And Outputs From Multiple Collaborations At AACR

June 22, 2020

BERG Announces Presentation Of Multiple Interrogative Biology Platform® And Outputs From Multiple Collaborations At AACR

Press releases

June 18, 2020

Energy Department Uses Supercomputers to Tackle COVID-19

News
BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory’s Summit Supercomputer in the Fight Against COVID-19

June 17, 2020

BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory’s Summit Supercomputer in the Fight Against COVID-19

Press releases
BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 American Society of Clinical Oncology (ASCO) Meeting

June 1, 2020

BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 American Society of Clinical Oncology (ASCO) Meeting

Press releases
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions

May 6, 2020

BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions

Press releases

May 6, 2020

Boehringer Ingelheim adds second AI partner in a month

News
BERG Named Visionary in Frost & Sullivan’s First-Ever Frost Radar™ AI in Drug Discovery Report in the Pharmaceutical Industry

April 13, 2020

BERG Named Visionary in Frost & Sullivan’s First-Ever Frost Radar™ AI in Drug Discovery Report in the Pharmaceutical Industry

Press releases

March 5, 2020

Transforming Drug Discovery through Artificial Intelligence.

News
BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG’s Interrogative Biology® Platform

February 27, 2020

BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG’s Interrogative Biology® Platform

Press releases

February 15, 2020

The December 2019 issue of Nature magazine describes the unique potential of the BERG platform in combining patient biology & artificial intelligence for drug and clinical development, highlights its use in the development of BPM 31510 in oncology.

News

February 14, 2020

Pod of Asclepius Podcast: BERG CEO on Value-Driven Data & AI for Pharma Innovation

News

February 14, 2020

A.I. Cancer Drugmaker Meeting with Big Pharma Companies

News
BERG Presents Data Demonstrating That BPM31510 Promotes Cytotoxic T-cell Function And Influences Checkpoint Receptor Expression Patterns To Potentially Synergize Anti-Cancer Effect In Combination With I/O Therapies

February 14, 2020

BERG Presents Data Demonstrating That BPM31510 Promotes Cytotoxic T-cell Function And Influences Checkpoint Receptor Expression Patterns To Potentially Synergize Anti-Cancer Effect In Combination With I/O Therapies

Press releases
BERG Presents Initial Clinical Data And Identification Of Response Biomarkers In A Phase 2 Pancreatic Cancer Trial Guided By Using The Interrogative Biology® Platform At ASCO-GI Meeting

January 29, 2020

BERG Presents Initial Clinical Data And Identification Of Response Biomarkers In A Phase 2 Pancreatic Cancer Trial Guided By Using The Interrogative Biology® Platform At ASCO-GI Meeting

Press releases

January 29, 2020

Why big pharma sees a remedy in data and AI

News
BERG Collaboration Identifies Novel Mechanism Of Action Of Redox Regulation By BPM 31510 In Models Of Glioblastoma

October 22, 2019

BERG Collaboration Identifies Novel Mechanism Of Action Of Redox Regulation By BPM 31510 In Models Of Glioblastoma

Press releases
BERG PRESENTS FIRST-IN-KIND DATA USING ITS BAYESIAN AI-DRIVEN INTERROGATIVE BIOLOGY® TECHNOLOGY TO MAP UNDERLYING BIOLOGY OF PATIENT RESPONSES IN ADVANCED SOLID TUMOR TRIAL OF BPM31510

September 28, 2019

BERG PRESENTS FIRST-IN-KIND DATA USING ITS BAYESIAN AI-DRIVEN INTERROGATIVE BIOLOGY® TECHNOLOGY TO MAP UNDERLYING BIOLOGY OF PATIENT RESPONSES IN ADVANCED SOLID TUMOR TRIAL OF BPM31510

Press releases
BERG Presents Key Findings From Two Important Clinical Initiatives At The 2019 ASCO Annual Meeting: BERG’s Final Phase 1 Results For BPM 31543 In Chemotherapy-Induced Alopecia And A Clinical Study Using BERG’s Interrogative Biology® Platform Demonstrating The Importance Of Altruism In Pancreatic Cancer Biomarker Discovery

June 3, 2019

BERG Presents Key Findings From Two Important Clinical Initiatives At The 2019 ASCO Annual Meeting: BERG’s Final Phase 1 Results For BPM 31543 In Chemotherapy-Induced Alopecia And A Clinical Study Using BERG’s Interrogative Biology® Platform Demonstrating The Importance Of Altruism In Pancreatic Cancer Biomarker Discovery

Press releases
BERG ANNOUNCES DATA PRESENTATIONS AT AACR 2019 DEMONSTRATING EFFICACY OF BPM 31510 IN GLIOBLASTOMA AND IDENTIFICATION OF NOVEL PROSTATE AND PANCREATIC CANCER BIOMARKERS

March 29, 2019

BERG ANNOUNCES DATA PRESENTATIONS AT AACR 2019 DEMONSTRATING EFFICACY OF BPM 31510 IN GLIOBLASTOMA AND IDENTIFICATION OF NOVEL PROSTATE AND PANCREATIC CANCER BIOMARKERS

Press releases

November 26, 2018

Drugmakers embracing AI’s utility to uncover hidden opportunities in discovery

News

November 24, 2018

Drugmakers embracing AI’s utility to uncover hidden opportunities in discovery

News

BERG in the News!

BERG is making headlines.  Click here to see the latest breaking news, interviews, and press releases.